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Since the discovery of properdin by Pillemer et al. (1) in 1954, it has been
recognized that the alternative pathway ofthe complement system plays a major
role in natural resistance against microbial infection. Early studies demonstrated
that the alternative pathway functioned in bacteriolysis (2), neutralization of
viruses (3), and protozoal killing, (4, 5). The critical role of the alternative
pathway in bacterial opsonization was documented later in classic studies by
Wood and his co-workers (6-8) utilizing pneumococci. These studies suggested
that natural antibodies and the alternative pathway interacted functionally to
facilitate opsonization of pneumococci (8). Since then, several bacterial species
have been shown to activate the alternative pathway in serum and to utilize this
pathway during opsonization by serum (reviewed in reference 9). However, little
is known about the molecular dynamics of alternative pathway activation by
bacteria, the role ofantibodies and other serum factors in this process, and the
relative contributions ofthe alternative pathway and auxiliary factors to opsonic
recognition by phagocytic cells.
We have used a model system comprising the six isolated proteins of the
alternative pathway to study the opsonic capacity of this pathway for Bacteroides
fragilis and Bacteroides thetaiotaomicron in the absence ofother factors. B. fragilis
and B. thetaiotaomicron are normal components of the intestinal microflora and
have a symbiotic relationship with the host under normal circumstances . Clinical
infections due to these bacteria usually occur as a result of perturbation of the
intestinal mucosa with liberation of bacteria into the surrounding tissues. Pre-
vious studies from our laboratory have demonstrated that clinical isolates of B.
fragilis and B. thetaiotaomicron are resistant to the bactericidal activity of serum
but are readily opsonized by serum, which facilitates phagocytosis and intracel-
lular killing by polymorphonuclear leukocytes in vitro (10, 11). Involvement of
the alternative pathway in opsonization ofthese bacteria has been demonstrated
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using sera depleted of alternative pathway proteins and the respective isolated
proteins to restore opsonic activity to these sera (10). The present study dem-
onstrates that activation of the alternative pathway by B. fragilis and B. thetaio-
taomicron and resultant C3 deposition on the bacterial surfaces does not require
auxiliary serum factors, but the effector phase of opsonization of these bacteria
involving adherence, uptake, and killing of the bacteria by polymorphonuclear
leukocytes is dependent on such factors.
Materials and Methods
Bacterial Strains and Growth Conditions.
￿
B. fragilis 1365 and B. thetaiotaomicron 1343
were clinical isolates used in our previous studies (10). Stock cultures were maintained in
thioglycolate medium (Difco Laboratories, Detroit, MI) in frozen form at -70 °C. Cultures
were thawed and inoculated into broth consisting of equal parts of trypticase soy broth
(BBL Microbiology Systems, Cockeysville, MD) and brain-heart infusion broth (Difco
Laboratories) supplemented with 0.05% thioglycolate (Difco Laboratories). For prepara-
tion of radiolabeled bacteria, broth was supplemented with 10 'UCi/ml ofL-[sH]amino acid
mixture (New England Nuclear, Boston, MA). Cultures were incubated for 20 h at
37 °C in an anaerobic glove box (Coy Manufacturing Products, Ann Arbor, MI), which
was monitored to contain 85% nitrogen, 10% hydrogen, 5% carbon dioxide, and not
more than 20 parts per million of oxygen. Bacteria were washed and resuspended in
HBSS (M . A. Bioproducts, Walkersville, MD) containing 0.1 % gelatin (Difco Laboratories)
(HBG)'; this solution was boiled for 10 min before use to remove oxygen.
Isolation of Complement Proteins and IgM.
￿
C3 was prepared from human plasma by the
method of Tack et al. (12). Trace contaminants were removed by chromatography on
anti-IgG Sepharose 4B, anti-IgA Sepharose 4B, and anti-C5 Sepharose 4B equilibrated
with isotonic veronal-buffered saline (VBS), pH 7.4. Antisera to IgG (7-chain-specific),
IgA (-y-chain-specific), and C5 were obtained from Behring Diagnostics, LaJolla, CA, and
IgG fractions of these antisera were prepared by ammonium sulfate precipitation (13).
The IgG fractions were coupled to Sepharose 4B (Pharmacia Fine Chemicals, Piscataway,
NJ) by cyanogen bromide activation (14).
Factor B was prepared by a minor modification of the method of Gotze and Muller-
Eberhard (15). Human serum was precipitated with 40% ammonium sulfate (wt/vol) at
4°C, and the precipitate was discarded. The ammonium sulfate concentration in the
supernatant was raised to 68% . The resulting precipitate was solubilized and then
chromatographed according to the original procedure, except DEAF Sephacel (Pharmacia
Fine Chemicals) was substituted for DEAE-cellulose. As a final step in the purification
procedure, active fractions from the DEAE Sephacel column were chromatographed on
anti-IgG Sepharose 4B.
Factor D was prepared by the method of Davis et al. (16), except CM-Sepharose CL-
6B (Pharmacia Fine Chemicals) was substituted for CM-Sephadex. Final purification was
achieved by chromatography on a 2.6 x 90-cm column of Sephadex G-75 (Pharmacia
Fine Chemicals).
Factor H was harvested from the DEAE Sephacel column used in purification of C3.
Fractions containing factor H were dialyzed at 4°C against 0.008 M EDTA, pH 5.5, to
precipitate euglobulin. The precipitate was dissolved in VBS containing 0.01 M EDTA
and 0.1 % sodium azide and then chromatographed on a 5 .0 x 44-cm column of Bio-Gel
A-1 .5 M (Bio-Rad Laboratories, Inc., Richmond, CA) equilibrated with the same buffer.
Factor H containing fractions were further purified by chromatography on anti-IgG
Sepharose 4B.
Factor I was prepared by successive chromatography of human plasma on anti-factor
I Sepharose 4B, DEAE Sephacel, and anti-IgG Sepharose 4B (17). Trace transferrin was
removed by chromatography on anti-transferrin Sepharose 4B. Antiserum to factor I was
raised in a goat by repeated subcutaneous injections of purified factor I incorporated into
' Abbreviations used in this paper:
￿
HBG, HBSS- gelatin buffer; VBS, veronal-buffered saline.CFA (Difco Laboratories).
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PurityofIsolated Proteins.
￿
Purity of isolated protein preparations was assessed by SDS-
PAGE, double immunodiffusion, and ELISA. SDS-PAGE was performed by the method
of Laemmli (22) in a 10% polyacrylamide slab gel. Three to 5 lAg ofprotein were applied
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R-250, and clestained with an aqueous solution of 7.5% glacial acetic acid and 5%
methanol.
Double immunodiffusion was carried out at room temperature for 18 h in 0.6% agarose
in 0.01 M PBS, pH 7 .0, using antisera to human Clq, C4, C2, C3, C5, factor B, factor I,
factor H, properdin, IgG, IgM, IgA, albumin, fibronectin, transferrin, and whole human
serum. Final isolated preparations were tested at physiological concentration. Anti
human C3, C4, factor H, and factor I were prepared in goats by repeated subcutaneous
injections of isolated proteins incorporated into Freund's complete adjuvant; isolated C3,
factor H, and factor I were prepared as described above, and C4 was obtained from
Cordis Laboratories, Inc., Miami, FL. Other antisera were obtained commercially from
Behring Diagnostics (anti-IgG, IgA, IgM, Clq, C5, factor B, albumin, fibronectin, trans-
ferrin, and whole human serum), Atlantic Antibodies (anti
Immunodiagnostics Inc., San Marcos, CA (anti-C2). Antisera to the immunoglobul
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ration was highly purified as assessed by SDS-PAGE and double immunodiffusion as
described above. The inner wells of microtiter plates were coated for 18 h at 4°C with
100 AI of IgG standard (10-0.001 ug/ml), IgM (10,ug/ml), or a mixture of the six isolated
complement proteins at physiological concentrations in 0.1 M sodium bicarbon-
ate/carbonate buffer, pH 9.6. The plates were washed extensively with 0 .15 M phosphate
buffer, pH 7.4, containing 0 .5 M sodium chloride and 0 .05% Tween 20 (PBS-tween).
100 AI of alkaline phosphatase-labeled affinity-purified anti-human IgG (Sigma Chemical
Co., St. Louis, MO) diluted 1 :1,000 in PBS-tween was added, and the plates were incubated
for 2 h at room temperature. After additional washing with PBS-tween, 100 Al of p-
nitrophenyl phosphate (Sigma Chemical Co.) at a concentration of 1 mg/ml in 0.05 M
sodium bicarbonate/carbonate buffer, pH 9.8, containing 0.001 M magnesium chloride
was added to the wells. The plates were incubated at room temperature for 15 min, and
the reaction was stopped by addition of 50 A1 of 3 N sodium hydroxide. The absorbance
at 405 nm was measured using an ELISA reader (Litton Bionetics Inc., Charleston, SC).
Radioiodination of Proteins.
￿
C3 and IgM were radioiodinated by the lactoperoxidase
method using Enzymobeads from Bio-Rad Laboratories and the manufacturer's general
directions. For radioiodination of C3, purified C3 (100 Ag), 300 uCi of sodium
1251
(Amersham Corp., Arlington Heights, IL), 25 jul of Enzymobead reagent, 20 ul of 1% 0-
D-glucose, and 40 Al of 0.2 M sodium phosphate buffer, pH 7.2, in a total volume of 100
Al were incubated for 30 min on ice. For radioiodination of IgM, 500 JAg of purified IgM
and 250 ACi of sodium 1251 were used. Free iodine was removed by chromatography on
Sephadex G-25 (Pharmacia Fine Chemicals) equilibrated with VBS. Specific activity of
the radioiodinated C3 preparations ranged from 0.47 to 1 .73 1Ci/kg. Specific activity of
radioiodinated IgM was 0 .13 uCi/ug. Titration of C3 hemolytic activity (25) showed that
hemolytic activity in radioiodinated C3 was equivalent to that in nonlabeled C3 on a
weight basis; C3 hemolytic activity was titrated using complement components and
erythrocyte intermediate from Cordis Laboratories, Miami, FL. Radioiodinated and
nonlabeled IgM also had similar functional activity as assessed by comparing the ability of
these preparations to opsonize B. thetaiotaomicron together with the six isolated alternative
pathway proteins.
Preparation ofIsolated Complement Mixtures.
￿
Isolated complement proteins were mixed
at physiological concentrations as described previously (26). C3, factor H, and factor I
were incubated for 30 min at 37°C. Factor B, factor D, and properdin or combinations
of these proteins were then added. Final protein concentrations were: 1,200 Ag/ml C3;
200 Wg/ml factor B; 2 Ag/ml factor D; 500 ,ug/ml factor H; 34 tag/ml factor 1; and 20
/Ag/ml properdin. The mixtures were supplemented with 0.005 M magnesium chloride
and 0.0015 M calcium chloride before use in the experiments.
Serum Lacking Classical Pathway Activity (EGTA-serum). Pooled human serum was
treated with 0.01 M EGTA and 0.01 M magnesium chloride to block classical pathway
activity and allow selective complement activation via the alternative pathway. Total
hemolytic complement was not detected in this serum, confirming that classical pathway
activity was effectively inhibited. Total hemolytic complement was measured by the
method of Mayer (27).
Functional Testing ofIsolated Proteins.
￿
C3 deposition on rabbit and sheep erythrocytes
in mixtures of the isolated complement proteins and in serum was performed by the
method of Schreiber et al. (28). Isolated protein mixtures or serum were supplemented
with radioiodinated C3 and centrifuged at 10,000 g for 3 min at 4°C to remove possible
aggregates. The amount of labeled C3 added to the serum was adjusted so that the final
samples analyzed contained -105 total cpm. Equal parts of protein mixture or serum and
erythrocytes (109 cells/ml) were incubated at 37 °C. At various time intervals, aliquots
were removed and rapidly centrifuged through 20% sucrose in VBS to separate cell-
bound and free radioactivity. The number of C3 molecules bound per erythrocyte was
calculated by multiplying the percent of C3 deposition by the number of C3 molecules
added per erythrocyte.
To detect possible fluid phase consumption of C3, mixtures of the six isolated comple-
ment proteins were incubated for 15 min at 37'C or VC, C, and C3 hemolytic activity wasBJORNSON ET AL.
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titrated in these mixtures. Results were compared with those obtained with a control C3
preparation that was not incubated.
Quantitation of C3 Deposition on Bacteria.
￿
Isolated protein mixtures or serum were
supplemented with radioiodinated C3 and centrifuged as described above. Equal parts of
protein mixture or serum and bacteria (108 CFU/ml) were incubated at 37°C. At various
times intervals, aliquots were removed and rapidly centrifuged through 20% sucrose in
VBS to separate bacterial-bound and free radioactivity. Results were expressed as C3
molecules bound per CFU, which was calculated by multiplying the percent C3 deposition
by the number of C3 molecules added per CFU.
Opsonization of the Bacteria.
￿
Equal parts of 'H-labeled bacteria (108 CFU/ml) and
isolated complement mixture or serum were incubated at 37 °C in the anaerobic glove
box. IgM (750 ,ug/ml) was included in the reaction mixtures in some experiments. After
15, 30, or 45 min of incubation, the bacteria were washed once and resuspended in
deoxygenated HBG except where otherwise indicated in the Results.
Preparation of Polymorphonuclear Leukocytes. Polymorphonuclear leukocytes from
healthy adult donors were isolated by centrifugation of heparinized blood on Hypaque-
Ficoll (29). Contaminating erythrocytes were removed by hypotonic lysis with 0.2% sodium
chloride; isotonicity was restored by addition ofan equal volume of 1 .6% sodium chloride.
Leukocytes were washed and resuspended in deoxygenated HBG. Suspensions contained
98% or more polymorphonuclear leukocytes.
Measurements of Bacterial Uptake and Killing.
￿
Opsonized bacteria and polymorphonu-
clear leukocytes at final concentrations of 2.5 X 107 cellsor CFU/ml were rotated at 37 ° C
in the anaerobic glove box. After 5, 10, and 20 min of incubation, bacterial uptake and
killing were measured in duplicate using minor modifications of previously published
methods (11). For measurement of bacterial uptake, aliquots were centrifuged at 190 g
for 5 min at 4°C. The leukocytes were washed three times with cold deoxygenated HBG.
Leukocyte pellets and samples removed before incubation for measurement of input
counts per minute were solubilized and counted. For measurement of killing, aliquots
removed before and after incubation were serially diluted in deoxygenated distilled water
and plated by the pour plate method in agar consisting of equal parts of trypticase soy
agar (BBL Microbiology Systems) and brain-heart infusion agar (Difco Laboratories)
supplemented with 0.5% yeast extract (BBL Microbiology Systems) and 0.05% thiogly-
colate. Percent uptake, reflecting both adherent and ingested bacteria, was calculated by
dividing the counts per minute in the leukocyte pellets by the input counts per minute
and multiplying by 100. Percent killing was calculated by the formula (a - b)/a X 100,
where a and b were equal to surviving CFU/ml before and after incubation, respectively.
In some experiments, direct killing of the bacteria by pooled human serum was
determined. Bacteria (108 CFU/ml) were incubated at 37 °C with 50% serum (vol/vol),
and surviving bacteria were enumerated at 30 and 60 min as described above.
MeasurementofBacterialAdherence to PolymorphonuclearLeukocytes.
￿
Two methods were
used to measure adherence of opsonized bacteria to polymorphonuclear leukocytes. In
the first method, polymorphonuclear leukocytes were treated for 15 min at room tem-
perature with 10 ug/ml of cytochalasin B to inhibit ingestion. Cytochalasin B-treated
polymorphonuclear leukocytes and opsonized bacteria were rotated at 37 °C at final
concentrations of 2.5 X 107 cells or CFU/ml. After 5, 10, and 20 min of incubation,
bacterial uptake was measured as described in the preceding section, except the leukocytes
were washed twice rather than three times before solubilization and counting.
In the second method, polymorphonuclear leukocytes were incubated for 30 min at
4°C with 10 ug/ml cytochalasin B. Equal volumes of opsonized bacteria (2.5 X 107
CFU/ml) and polymorphonuclear leukocytes (2.5 X 108/ml) were incubated with gentle
tumbling at 4°C. After 30 min and 18 h of incubation, 30,I aliquots were removed, and
5 pl of 0 .015% acridine orange in HBSS was added to each aliquot. Sealed wet mounts
were prepared, and the number of bacteria adhering to 100 polymorphonuclear leuko-
cytes was counted using a Zeiss fluorescent microscope (Carl Zeiss, Inc., Thornwood, NY).
Preliminary experiments confirmed that cytochalasin B inhibited ingestion of serum
opsonized bacteria by polymorphonuclear leukocytes under both sets of conditions.782 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
Analysis of Bacteria-bound C3 Fragments .
￿
Isolated protein mixtures or serum were
supplemented with 2.8 x 10 7 cpm/ml radioiodinated C3 and centrifuged at 10,000 g for
3 min at 4°C to remove possible aggregates. Equal parts of bacteria (10s CFU/ml) and
protein mixture or serum in a volume of 500,u1 were incubated for 30min at 37°C . The
bacteria were then washed twice with deoxygenated HBSS . Bacteria-bound C3 was
extracted, quantitated, and analyzed as described by Weis et al. (30). Briefly, the bacterial
pellets were incubated for 60 min at 37°C in 0 .1 M carbonate/bicarbonate buffer, pH
11, containing 0.025 M methylamine and 1% SDS . The bacteria were centrifuged, and
radioactivity in the pellets and supernatants was counted . The percent extracted C3 was
calculated by dividing the radioactivity in the supernatants by the sum of the radioactivity
in the pellets and supernatants and then multiplying by 100 . Supernatants containing
extracted C3 were subjected to 6-12% linear gradient SDS-PAGE under reducing
conditions, and C3 cleavage fragments were analyzed by autoradiography . Prestained
protein standards from Bethesda Research Laboratories, Gaithersburg, MD, were used in
these analyses .
Binding ofIgM to the Bacteria .
￿
Nonlabeled IgM was supplemented with radioiodinated
IgM so that the final samples analyzed contained ^-105 total cpm . Bacteria (10' CFU/ml)
were incubated for 30 min at 37°C with 750 ug/ml of the trace-labeled IgM . After
incubation, triplicate samples were rapidly centrifuged through 20% sucrose in VBS, and
bacterial-bound and free radioactivity was measured . Results were expressed as IgM
molecules bound per CFU and were calculated by multiplying the percent of bound IgM
by the number of IgM molecules added per CFU .
Results
ofIsolated Complement Proteins .
￿
Isolated prepa-
rations of the six proteins of the alternative pathway used in our investigation
were highly purified as assessed by SDS-PAGE (Fig . 1) . The isolated proteins
reacted in double immunodiffusion only with homologous antisera and formed
FIGURE 1.
￿
SDS-PAGE of isolated C3 (C3), factor 1-I (H), factor 1 (1), factor B (B), factor D
(D), and properdin (P) under reducing conditions . Numbers on the left refer to the positions
ofstandard proteins having the indicated M,. x 10-5.0
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Kinetics of '21I-C3 deposition on~rabbit erythrocytes during incubation with the
alternative complement pathway reconstructed from isolated proteins. Rabbit erythrocytes
were incubatedat 37°C with acomplete mixtureof thesix isolated complement proteins (solid
circles), a mixtureof five proteins lacking factor D (solid squares), or properdin (solid triangles),
the complete mixture heat-inactivated at 56°C for 30 min (open squares), or EGTA-serum
(open circles). At thespecified time intervals, thenumber ofC3 moleculesboundpererythrocyte
wasquantitated. Data areexpressed as mean f SEM ofthree to four determinations.
a single precipitin line with antiserum to whole human serum, except factor D
which was nonreactive.
The alternative pathway was reconstructed by mixing the six isolated comple-
ment proteins at physiological concentrations. This mixture was devoid of IgG
as assessed by the ELISA; the lower limit of detection of IgG in this assay was
0.01 jig/ml of IgG. Functional activity of the isolated proteins was determined
by comparing "5I-C3 deposition on rabbit erythrocytes during 30 min of incu-
bation at 37°C with the complement mixture and EGTA-serum. C3 deposition
was also measured during incubation of the erythrocytes with mixtures of five
isolated proteins (lacking factor D, factor B, or properdin) and with a mixture
of the six proteins heat-inactivated at 56°C for 30 min. The kinetics of C3
deposition on rabbit erythrocytes were similar during incubation with the com-
plete protein mixture and EGTA-serum (Fig. 2). The magnitude ofthe response
was 1.3-fold greater in the isolated mixture, a finding consistent with previous
data comparing C3 deposition on particulate activators ofthealternativepathway
in isolated complement mixtures and serum under conditions similar with those
used in our study (28, 31). Deletion of properdin from the protein mixture
markedly reduced C3 deposition, and deletion of factor D resulted in a back-
ground level of C3 deposition equal to that observed with the heat-inactivated
protein mixture. Similar results were obtained with the mixture ofcomplement
proteins lacking factor B (data not shown). These data confirm previous obser-784 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
TABLE I
Lack ofSpontaneous C3 Consumption in the Alternative Complement
PathwayReconstructedfrom Isolated Proteins
Complete mixtures ofthesixisolated complement proteins were incubated
for 15 min at the specified temperatures, and C3 hemolytic activity was
titrated in these mixtures andin an equivalent amount of C3 alone. Data
are from a representative experiment.
vations demonstrating an absolute requirement for factors B and D for alternative
pathway activation and augmentation of this process by properdin (26).
Two approaches were used to rule out spontaneous consumption of C3 in the
alternative pathway reconstructed from isolated proteins. First, complete mix-
tures of the six isolated complement proteins were incubated for 15 min at 37'C
or VC, C, and C3 hemolytic activity in these mixtures was compared with that in
an equivalent amount of C3 alone. Hemolytic activity was equivalent in the
protein mixtures and the control C3 preparation, ruling out C3 consumption in
the fluid phase (Table I). Secondly, 1251-C3 deposition was measured on sheep
erythrocytes, a nonactivator of the alternative pathway, during 30 min of
incubation at 37°C with the complete protein mixture (untreated and heat-
inactivated), EGTA-serum, and untreated serum. <10' C3 molecules were de-
posited per erythrocyte after 30 min of incubation with both protein mixtures
and EGTA-serum. In contrast, 2.0 X 105 C3 molecules were deposited per
erythrocyte after incubation with untreated serum (containing both classical and
alternative complement pathway activity). These data further negate fluid-phase
C3 consumption in the complete mixture of isolated complement proteins.
Alternative Pathway Activation by Bacteroides.
￿
Serum opsonization of the iso-
lates of B. fragilis and B. thetaiotaomicron used in our investigation has been
previously shown to involve the alternative pathway (10). To determine the
capacity of these bacteria to activate the alternative pathway, 125I-C3 deposition
on the bacteria was measured during 60 min of incubation at 37 0 C with the
complete mixture of six isolated complement proteins or EGTA-serum. Bacteria
incubated with a mixture of five complement proteins lacking factor D and with
a heat-inactivated complete protein mixture served as the negative controls. C3
deposition on the Bacteroides strains was demonstrated during incubation with
the complete protein mixture with maximal levels of 1 .4-1 .7 X 105 C3 molecules
per CFU occurring by 45 min of incubation (Fig. 3). Maximal deposition of 1 .9-
2.7 X 105 C3 molecules per CFU occurred by 30 min of incubation with EGTA-
serum. C3 deposition was minimal in the incomplete protein mixture (lacking
factor D) and the heat-inactivated protein mixture. These data demonstrate that
B. fragilis and B. thetaiotaomicron are potent activators of the alternative pathway
Protein mixture Temperature of
incubation
C3 hemolytic
activity (CH5o)
°C U/ml
Complete 37 3,040
Complete 4 2,580
C3 Unincubated 2,520O
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FIGURE 3.
￿
'25I-C3 deposition on B. fragilis and B. thetaiotaomicron during incubation with
isolated protein mixtures or EGTA-serum. Bacteria were incubated at 37°C with a complete
mixture of the six isolated complement proteins (untreated [solid circles] or heat-inactivated at
56°C for 30 min [open squares]), a mixture of five proteins lacking factor D (solid squares), or
EGTA-serum (open circles). At the specified time intervals, the number ofC3 molecules bound
per CFU wasquantitated. Data areexpressed as mean ± SEMof five to nine determinations.
in the absence ofother factors. The data suggest that auxiliary factors in serum
augment activation of the alternative pathway by the Bacteroides strains.
Opsonic Capacity of the Alternative Pathwayfor Bacteroides.
￿
To determine the
opsonic capacity ofthe alternative pathway for theBacteroidesstrains, thebacteria
were opsonized with isolated protein mixtures or EGTA-serum, washed, and
incubated at 37°C with polymorphonuclear leukocytes. Bacterial uptake and
killing were measured during 20 min of incubation. The conditions used for
opsonizing the bacteria were identical to those used for measurements of C3
deposition, so that the results could be compared. Bacteria were opsonized with
the various complement sources for 30 min at 37 0C, because C3 deposition on
the bacteria was maximal or near maximal at this time (refer to Fig. 3). Prelimi-
nary experiments demonstrated that heat inactivation of EGTA-serum at 56°C
for 30 min ablated bacterial uptake and killing, indicating that complement was
essential for opsonization (data not shown). Opsonization of the bacteria with
isolated protein mixtures (complete or lacking factor D) promoted minimal
uptake and killing by the leukocytes, whereas 80-90% uptake and killing were
observed when the bacteria were opsonized with EGTA-serum (Figs. 4 and 5).
The bacteria were not susceptible to direct killing by serum (data not shown),
and bacterial uptake and killing by the leukocytes were not demonstrated in the786 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
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FIGURE 4.
￿
Uptake and killing by polymorphonuclearleukocytes of B.fragilis opsonized with
isolated protein mixtures or EGTA-serum. Bacteria were incubated for 30 min at 37 °C with
a complete mixture of the six isolated complement proteins (solid circles), a mixture of five
proteins lacking factor D (solid squares), EGTA-serum (open circles), or HBSS (open triangles).
After washing, the bacteria were further incubated with polymorphonuclear leukocytes, and
uptake and killing were measured at the specified time intervals. Data are expressed as mean
± SEM of two determinations.
absence of opsonins (Figs. 4 and 5). Opsonization of the bacteria with the
complement sources for 15 or 45 min yielded results similar to those obtained
when the bacteria were opsonized for 30 min (data not shown). These data taken
together with the results on C3 deposition demonstrate that alternative pathway
activation and C3 deposition alone are not sufficient to facilitate uptake and
killing of B. fragilis and B. thetaiotaomicron by polymorphonuclear leukocytes.
The results suggest that auxiliary serum factors are necessary to promote these
events.
Ability of the Alternative Pathway to Facilitate Adherence.
￿
For measurement of
bacterial adherence to polymorphonuclear leukocytes, the leukocytes were pre-
treated with cytochalasin Bunderconditions that were shown to inhibit ingestion.
In initial experiments, radiolabeled bacteria were opsonized with the complete
mixture of isolated complement proteins or EGTA-serum for 30 min at 37 0C,
and uptake by cytochalasin B-treated polymorphonuclear leukocytes was meas-
ured during 20 min of further incubation at 37°C . Under these conditions,
bacteria opsonized with isolated proteins adhered minimally to the polymorpho-
nuclear leukocytes, whereas a high level of adherence was observed when the
bacteria were opsonized with EGTA-serum (Fig. 6).
To determine whether these differences in adherence were related to quanti-Incubation (min)
FIGURE 5.
￿
Uptake and killing by polymorphonuclear leukocytes of B. thetaiotaomicron opso-
nized with isolated protein mixturesor EGTA-serum. Experimental conditions wereas outlined
in Fig. 4. Data are expressed as mean t SEM of two determinations.
tative differences in C3 deposition on the bacteria, C3 deposition mediated by
isolated proteins was increased by opsonizing the bacteria twice with these
proteins. This treatment resulted in binding of2.0 X 105 C3 molecules per CFU
on B. fragilis and 2.7 X 105 C3 molecules per CFU on B. thetaiotaomicron,
numbers equivalent to those bound to bacteria opsonized with EGTA-serum
(refer to Fig. 3). However, only a minor increase in adherence of the bacteria to
the polymorphonuclear leukocytes was observed (Fig. 6). These results indicate
that the difference in opsonic capacity of isolated proteins and EGTA-serum is
not solely related to the concentration ofbacteria-bound C3.
Additional experiments employed more stringent conditions for measurement
of adherence. In these experiments, the polymorphonuclear leukocytes were
treated with cytochalasin B at VC, C, and adherence of acridine orange stained
bacteria was measured by fluorescence microscopy after 30 min and 18 h of
incubation at VC. C. The ratio of bacteria to polymorphonuclear leukocytes in
these assays was 10:1 as compared with 1:1 in other experiments. B. fragilis
opsonized with isolated complement proteins adhered minimally to the polymor-
phonuclear leukocytes under these conditions (Table II). Similarly opsonized B.
thetaiotaomicron adhered to the polymorphonuclear leukocytes to a greater ex-
tent; however, adherence was considerably less than adherence of -bacteria
opsonized with EGTA-serum. These results provide additional support for the
concept that the alternative pathway is inefficient in facilitatingadherence ofthe
Bacteroides strains to polymorphonuclear leukocytes in the absence of other
factors.788 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
B. fragilis
￿
B. thetaiotamicron
100 1 100
0
Incubation (min)
10
￿
20
Adherence to polymorphonuclear leukocytes of B. fragilis and B. thetaiotaomicron
opsonized with isolated complement proteins or EGTA-serum. Bacteria were incubated for
30 min at 37 °C with a complete mixture of the six isolated complement proteins (solid circles),
EGTA-serum (open circles), or HBSS (open triangles). (Dotted line) Bacteria opsonized twice
with the isolated complement mixture. After washing, the bacteria were further incubated
with cytochalasin B-treated polymorphonuclear leukocytes, and uptake was measured at the
specified time intervals. Data are expressed as mean ± SEM of two determinations.
FIGURE 6.
TABLE II
Adherence ofOpsonized Bacteroides to Cytochalasin B-treated
Polymorphonuclear Leukocytes al 4'C
Bacteria were incubated for 30 min at 37 °C with a complete mixture of
six isolated complement proteins, EGTA-serum, or HBSS. After washing,
the bacteria were incubated with cytochalasin B-treated polymorphonu-
clear leukocytes at 4°C. Adherence was measured microscopically after
30 min and 18 h of incubation.
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Adherence
Complement source used B. fragilis B. thetaiotaomicron for opsonization
30 min 18 h 30 min 18 h
Isolated proteins 8 4 18 20
EGTA-serum 45 62 42 61
HBSS 4 2 2 11BJORNSON ET AL .
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FIGURE 7 .
￿
Autoradiograph of SDS-PAGE analysis of "5I-C3 extractedby methylamine and
SDS fromB . fragilis and B . thetaiotaomicron opsonizedwith isolated complement proteins and
EGTA-serum. Tracks 2 and 3 contain extracts from B . fragilis and tracks 4 and 5, extracts
from B . thetaiotaomicron . Bacteria were opsonized with a complete mixture of the six isolated
complement proteins (tracks 2 and 4) or EGTA-serum (tracks 3 and 5) . Track 1 contained '45I-C3 . Numbers on the left refer to the positions of standard proteins having the indicated
M, x 10-s .
Character ofBacteria-bound C3 Fragments.
￿
The molecular form of thebacteria-
bound C3 fragments generated by alternative pathway activation in isolated
complement proteins and EGTA-serum was next compared . B. fragilis and
B. thetaiotaomicron were opsonized for 30 min at 37°C with the complete mixture
of isolated proteins or EGTA-serum and then washed . Bacteria-bound 1251-C3
was extracted by treatment with methylamine and SDS, and the extracted C3
was quantitated and analyzed by SDS-PAGE and autoradiography . Of the cell-
bound radioactivity, 75% was extracted from both bacterial strains opsonized
with isolated proteins or serum . Autoradiographic analysis revealed that all
extracts contained the (3 chain of C3 (70,000 mol wt), the a chain of Cab
(100,000 mol wt), the 67,000-mol wt fragment of the a chain of iC3b, and high
molecular weight material (>100,000) presumably representing the a chain of
C3 bound by amide bonds to bacterial surface constituents extracted by meth-
ylamine andSDS (Fig . 7) . A 45,000-mot wt band was barely visible in all extracts
and presumably represents the smaller fragment of the a chain of iC3b that is
poorly labeled by the iodination method used (30) . Extracts from bacteria
opsonized with isolated proteins also contained a faint band at 20,000 mol wt
that was not observed in extracts from bacteria opsonized with EGTA-serum . A
band at 110,000 mol wt was also observed that was barely visible in extracts
from serum-opsonized bacteria .790 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
TABLE III
Semiquantitative Comparison ofthe Molecular Form of C3 in
Extractsfrom Bacteroides Opsonized with Isolated
Complement Proteins or EGTA-Serum
"'I-C3 in each form
B.fragilis
￿
B. thetaiotaomicron
M,
￿
opsonized with
￿
opsonized with
The dried gel was aligned with the autoradiograph (Fig. 7), and labeled
bands or areasof the gel were removedand counted in a gamma counter.
The percent C3 in each form was determined by the following equation:
[(cpm in band)/area]/[(cpm of bandsof >100,000 M,) + (cpm of 100,000-
M, band) + (cpm of 67,000-M,band) + (cpm of bands <60,000 M,)].
Semiquantitation ofthe 67,000 and 100,000 mol wt bandsrevealed that -30-
40% of the C3 extracted from both Bacteroides strains was in the form of iC3b
and ^-10% in the form ofC3b (Table III). Extracts from bacteria opsonized with
isolated proteins contained slightly less iC3b (67,000 mol wt band) and more low
molecular weight C3 (<60,000) than extracts from serum-opsonized bacteria,
presumably reflecting limited proteolytic cleavage of iC3b . The 20,000 mol wt
band in extracts from bacteria opsonized with isolated proteins was not quanti-
tatedseparately from the 45,000 molwt band, because ofthelimitedradioactivity
in this section of the gel. However, the percentage of the total extracted
radioactivity represented by the 20,000 mol wt band was estimated to be 4-5%.
The percentage ofhigh-molecular-weight C3 was similar in the various extracts.
These results demonstrate that the predominant form of C3 bound by ester
bonds to the Bacteroides strains through alternative pathway activation is iC3b
and suggest that limited proteolytic cleavage of the bound iC3b occurred during
opsonization of the bacteria with isolated proteins.
Contribution of Antibodies to Opsonization.
￿
We previously reported that anti-
bodies in normal human serum contribute to opsonization ofBacteroides (10, 32,
33). These antibodies belong primarily to the IgM class and are directed against
strain-specificantigenic determinants contained in thebacterial outer membrane
complex (32, 33). The role of natural IgM antibodies as auxiliary factors in
opsonization of Bacteroides by the alternative pathway was therefore explored.
The purified IgM used in these studies was prepared from a pool of normal
human serum, so that antibodies in this preparation would be representative of
a broad range of donors. The IgM preparation was highly purified as assessed
by SDS-PAGE, reacted in double immunodiffusion only with homologous anti-
serum, and contained <0.8% IgG by ELISA. The Bacteroides strains were
opsonized with purified IgM and the mixture ofsixalternativepathway proteins,
Isolated
proteins
EGTA-
serum
Isolated
proteins
EGTA-
serum
>100,000 38 39 37 40
100,000 11 12 11 10
67,000 33 37 30 37
<60,000 18 12 22 13m
Y m
n
100
80
80
40
20
FIGURE 8.
￿
Uptake and killing by polymorphonuclear leukocytes ofB. thetaiotaomicron opso-
nized with IgMandthealternative pathway. Bacteria were incubatedfor 30 minat 37°C with
purified normal IgM and a complete mixture of the six isolated complement proteins (solid
triangles), the complement mixture (solid circles) or IgM (open triangles) alone, EGTA-serum
(open circles), or HBSS (open squares). After opsonization,polymorphonuclear leukocytes were
added, and uptake andkilling were measured at thespecified time intervals. Data areexpressed
as mean ± SEM of twodeterminations.
IgM or the complement mixture alone, or EGTA-serum. In these experiments,
the bacteria were not washed after opsonization, because washing was found to
induce agglutination ofbacteria opsonized with purified IgM. After opsonization,
polymorphonuclear leukocytes were added, and uptake and killing were meas-
ured as in preceding experiments. Opsonization ofthe bacteria with IgM or the
alternative pathway proteins alone facilitated minimal uptake and killing by the
leukocytes (Figs. 8 and 9). The combination ofIgM andthe complement proteins
increased uptake and killing of B. thetaiotaomicron to the level observed with
EGTA-serum (Fig. 8). In contrast, IgM and the complement proteins minimally
increased uptake of B. fragilis and had no effect on killing of this organism.
Measurement ofIgM bindingto the Bacteroides strains under the conditions used
for opsonization showed that 1 .08 X 104 and 9.33 X 103 IgM molecules per CFU
bound to B. thetaiotaomicron and B. fragilis, respectively. Thus, the difference in
opsonic activity of IgM for the two bacterial strains was not related to a
quantitative difference in antibodies capable of opsonizing these strains. These
resultsindicate that natural IgM antibodies serve asauxiliaryfactors in alternative
pathway-mediated opsonization of B. thetaiotaomicron, whereas additional auxil-
iary factors arenecessary foropsonization ofB.fragilisby thealternative pathway.792 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
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FIGURE 9.
￿
Uptake and killing by polymorphonuclearleukocytes of B.fragilis opsonized with
IgMand thealternative pathway. Experimental conditions were as outlined in Fig. 8. Data are
expressedas mean ± SEM of twodeterminations.
We have used a model system comprising the six isolated proteins of the
alternative complement pathway to study the opsonic capacity of this pathway
for clinical isolates of B. fragilis and B. thetaiotaomicron under physiological
conditions. By using isolated alternative pathway proteins, we were able to
exclude participation ofother serum proteins that might influence opsonization
and complicate the interpretation ofour results. Rigorous criteria were used to
ensure purity ofthe isolated complement proteins including SDS-PAGE, double
immunodiffusion usingabatteryofmonospecific antisera directed againstvarious
complement proteins, immunoglobulins, and other serum proteins, and an
ELISA to rule out trace contamination with IgG. Measurement ofC3 deposition
using rabbit erythrocytes as the alternative pathway activator documented that
the isolated proteins functioned similarly to the alternative pathway in EGTA-
serum. Additional studies ruled out spontaneous activation of C3 in the model
system, which can be a major problem with this system due to artifactual
activation ofproperdin during purification.
We investigated both the early phase of opsonization involving activation of
the alternative pathway by the Bacteroides strains resulting in C3 deposition on
the bacterial surfaces and theeffector phase ofopsonization involvingrecognition
of bacteria-bound C3 by polymorphonuclear leukocytes and the induction of
phagocytosis and intracellular killing. Both Bacteroides strains were found to be
potent activators of the alternative pathway as evidenced by the deposition ofBJORNSON ET AL.
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-x105 C3 molecules per CFU when the bacteria were opsonized by isolated
alternative pathway proteins. However, C3 deposition was approximatelytwofold
greater when opsonization was mediated by EGTA-serum under similar condi-
tions. It should be noted that the conditions used for bacterial opsonization were
different from those used for measurement ofC3 deposition on rabbit erythro-
cytes; the bacteria were added to the assays at a 10-fold lower concentration than
the rabbit erythrocytes, because these conditions were found to maximize opson-
ization of the bacteria. In data not presented in this paper, measurement of C3
deposition using rabbit erythrocytes at the same concentration as the bacteria
revealed differences in functional activity between the isolated alternative path-
way proteins and EGTA-serumsimilar to those observed with the bacteria. These
results further support the functional integrity o£the model system ofalternative
pathway activation and suggest that factors are present in serum that augment
alternative pathway activation by the Bacteroides strains used in our study and
rabbit erythrocytes under certain experimental conditions.
Opsonization of the Bacteroides strains with isolated alternative pathway pro-
teins under the same conditions used for measurement ofC3 deposition did not
promote adherence, uptake, or killing of the bacteria by polymorphonuclear
leukocytes, whereas opsonization with EGTA-serum facilitated these events. We
considered that a critical number ofbacteria-bound C3 molecules exceeding 105
per CFU might be required for interaction of the bacteria with complement
receptors on the polymorphonuclear leukocytes, and this might explain why
opsonization with EGTA-serum but not isolated proteins was effective in facili-
tating adherence. To test this hypothesis, we opsonized the bacteria twice with
isolated complement proteins and achieved numbers of bound C3 molecules
comparable to those obtained upon opsonization of the bacteria with EGTA-
serum. However, the increase in bound C3 had a minimal effect on adherence
of the bacteria to polymorphonuclear leukocytes. These findings indicate that
the concentration of bacteria-bound C3 is not the sole determinant in opsonic
recognition of Bacteroides by polymorphonuclear leukocytes.
To determine whether protease inhibitors or other factors in serum protected
bacteria-bound C3 from the action of factor I or bacterial proteases, the molec-
ular form of C3 bound to bacteria opsonized with isolated alternative pathway
proteins and EGTA-serum was compared. Radioiodinated bound C3 was ex-
tracted from the opsonized bacteria using methylamine and SDS. The combina-
tion of nucleophilic agent and detergent has been previously shown to be highly
effective in releasing covalently bound and hydrophobically associated C3 from
bacteria (30), and this was confirmed by our studies. Comparable amounts ofC3
were extracted by this treatment from bacteria opsonized with isolated proteins
and EGTA-serum. The C3 extracts were analyzed by SDS-PAGE and autora-
diography, which enabled separation and semiquantitation of the various C3
fragments in the extracts. The predominant form of C3 in extracts from both
Bacteroides strains was iC3b. C3b was also present in all extracts but in lesser
amount. A low molecular weight cleavage fragment ofC3 migrating at ^20,000
was detected in extracts from bacteria opsonized with isolated proteins, and the
percentage of iC3b in these extracts was slightly lower than in extracts from
serum opsonized bacteria. These observations suggest that limited proteolytic794 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
cleavage of iC3b occurred in the model system of isolated proteins because of
the absence ofprotease inhibitorsorother factors present in serum. The cleavage
fragment formed is smaller than the tryptic cleavage fragments, C3dg and Cad.
It is doubtful that this mechanism can entirely account for the opsonic incapacity
ofthe isolated proteins, because proteolysis was so limited.
In a recent report, Newman et al. (34) haveshown that C3b is the predominant
form ofC3 bound to various bacterial pathogens after opsonization with serum.
The absence ofiC3b was striking and suggestive that proteolysis of C3b was not
a typical finding under short-term incubation. Our experiments, also using a
briefincubation period foropsonization, suggest that the Bacteroides isolates used
in our study were decidedly different from the bacteria used in Newman's study,
because they were predominantly coated with iC3b. This interesting difference
in results may be related to protease activity associated with Bacteroides, charac-
teristics of the cell envelope of these bacteria, or to other undefined factors.
It is well recognized that C3b and iC3b when bound to sheep erythrocytes
adhere to specific receptors for these ligands on polymorphonuclear leukocytes,
without participation of other factors (35, 36). However, there is minimal
information available regarding the relative opsonic activities of C3b and iC3b
when bound to bacteria. We previously demonstrated that the presence ofthese
C3 cleavage fragments on a laboratory isolate of Escherichia coli facilitated
adherence of the bacteria to polymorphonuclear leukocytes and also triggered
uptake and intracellular killing (37). iC3b was found to be only slightly less
effective than C3b in facilitating adherence ofthe E. coli strain to the leukocytes.
In the present study, the reason why Bacteroides bearing a mixed population of
iC3b and C3b did not adhere to polymorphonuclear leukocytes is speculative at
present. One possible explanation is that the C3 fragments may have been
impeded from interacting with the polymorphonuclear leukocytes possibly be-
cause of the physical characteristics of the moieties to which the fragments bind
or to their topographical location in the bacterial cell envelope. A second
explanation is that iC3b when bound to certain structures may require an
auxiliary serum factor for avid binding to CR3. In this regard, there is evidence
in the recent studies of Ross et al. (38) that CR3 contains two recognition sites,
one for binding of iC3b and a second with lectinlike properties that binds
zymosan. This latter site may also be involved in recognition of structurally
similar bacterial constituents, and the Bacteroides strains used in our study may
not possess these constituents.
Our study investigated the role of natural IgM antibodies as auxiliary factors
in opsonization of Bacteroides by the alternative pathway. These antibodies were
found to act synergistically with the alternative pathway to opsonize B. thetaio-
taomicron as effectively as EGTA-serum. However, similar numbers of IgM
antibodies directed against B.fragilis failed to effect opsonization ofthis organism
by the alternative pathway. Additional factors present in normal serum are
necessary for alternative pathway-mediated opsonization of B. fragilis, a finding
that may be ofsignificance in understanding the greater virulence ofthis species
as compared with B. thetaiotaomicron. Opsonization of B. fragilis may be depend-
ent on IgG antibodies, although antibodies ofthis class reactive with Bacteroides
are not usually present in normal serum (39). Other serum factors that mayBJORNSON ET AL.
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contribute to opsonization of B. fragilis are the membrane attack complex of
complement, fibronectin, and C-reactive protein. The role of these factors as
auxiliary opsonins for Bacteroides is currently under investigation in our labora-
tory.
The antibody independence ofalternative pathway activation by rabbit eryth-
rocytes (26, 28, 40), zymosan (41), E. coli (31, 37), Raji cells (42), measles virus-
infected cells (43), and immune complexes (44) has been documented in other
studies using similar model systems of isolated alternative pathway proteins.
Certain cytocidal effector functions of the alternative pathway also appear to
occur independently of antibody (26, 31, 42). For others, such as lysis ofmeasles
virus-infected cells and complement-mediated killing of Hemophilus infuenzae,
IgGantibodies are necessary for induction ofthe lytic phase (43, 45). Our results
have demonstrated that B. fragilis and B. thetaiotaomicron, like other potent
activators of the alternative pathway, activate this system without a requirement
for antibody. However, this activation process and the associated deposition of
C3 cleavage fragments on the bacterial surface is not sufficient by itself to
facilitate adherence, uptake, and killing of the bacteria by polymorphonuclear
leukocytes. The effector phase of opsonization, like cytolysis, is an alternative
pathway-dependent function that can require auxiliary serum factors. The con-
cept that the alternative pathway usually does not require auxiliary serum factors
applies only to the activation phase and should not be construed as a general
concept applying to effector functions as well.
Summary
Opsonization of clinical isolates of B. fragilis and B. thetaiotaomicron with the
six isolated proteins of the alternative complement pathway under physiological
conditions resulted in considerable C3 deposition on the bacterial surfaces. The
time course of C3 deposition was similar to that observed in EGTA-serum;
however, the magnitude of C3 deposition was twofold greater in EGTA-serum.
Opsonization ofthe bacteria with the isolated alternative pathway proteins failed
to promote adherence, uptake, or killing by polymorphonuclear leukocytes,
whereas opsonization of the bacteria with EGTA-serum facilitated these events.
The difference in opsonic capacity of isolated proteins and EGTA-serum was
not related to the quantitative difference in C3 deposition, because repeated
opsonization of the bacteria with isolated proteins resulting in C3 deposition
comparable to thatobserved in EGTA-serumonly minimally increasedadherence
of the bacteria to polymorphonuclear leukocytes. SDS-PAGE and autoradi-
ographic analysis ofC3 extracted from bacteria opsonized with isolated proteins
or EGTA-serum usingmethylamine and SDS demonstrated thatthe predominant
form of C3 bound by ester bonds under both sets ofconditions was iC3b . A low
molecular weight C3 cleavage fragment was detected in extracts from bacteria
opsonized with isolated proteins, but it accounted for only a minor fraction of
the bound C3. The results of our study demonstrate that the early phase of
opsonization involving activation of the alternative pathway by B. fragilis and B.
thetaiotaomicron and resultant C3 deposition on the bacterial surfaces does not
require auxiliary serum factors, but the effector phase of opsonization of these
bacteria involving recognition of bacteria-bound C3 by polymorphonuclear796 OPSONIZATION OF BACTEROIDES BY THE ALTERNATIVE PATHWAY
leukocytes and the induction of phagocytosis and intracellular killing is depend-
ent on such factors. Natural IgM antibodies serve as auxiliary factors is opsoni-
zation ofB. thetaiotaomicron by the alternative pathway, whereas additional serum
factors are required for alternative pathway-mediated opsonization of B. fragilis.
Receivedfor publication 8 September 1986 and in revisedform 24 November 1986.
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